Acumen Pharmaceuticals, Inc. (ABOS)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $75k
- Jun 17 · Unusual
- Form 4 sales
- 37
- On record
- Form 144 notices
- 6
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planJan 22 2026
Sold 4,160 shares at $1.83 ($8k)
Zuga Matt, CFO & Chief Business Officer
No 10b5-1 planSold 1.3% of holdings ($566k position)304,924 shares left0.3x usual sizeFiling
- 2 Form 4 saleNo planJan 22 same day
Sold 3,226 shares at $1.81 ($6k)
Siemers Eric, Chief Medical Officer
No 10b5-1 planSold 1.2% of holdings ($467k position)255,371 shares left0.3x usual sizeFiling
- 3 Form 4 saleNo planJan 23 +1 day
Sold 8,934 shares at $1.87 ($17k)
Meisner Derek M, Chief Legal Officer & Corp Sec
No 10b5-1 planSold 4.9% of holdings ($342k position)173,999 shares left0.5x usual sizeFiling
- 4 Form 4 saleRoutineJan 28 +5 days
Sold 17,756 shares at $3.00 ($53k)
Meisner Derek M, Chief Legal Officer & Corp Sec
10b5-1 planSold 9.3% of holdings ($575k position)173,999 shares left1.6x usual sizeFiling
- 5 Form 4 saleRoutineFeb 27 +30 days
Sold 9,406 shares at $3.01 ($28k)
Meisner Derek M, Chief Legal Officer & Corp Sec
10b5-1 planSold 5.1% of holdings ($552k position)173,999 shares left0.7x usual sizeFiling
- 6 Form 4 saleRoutineMar 6 +7 days
Sold 2,090 shares at $3.26 ($7k)
Meisner Derek M, Chief Legal Officer & Corp Sec
10b5-1 planSold 1.2% of holdings ($574k position)173,999 shares left0.2x usual sizeFiling
- 7 Form 4 saleNo planJun 9 +95 days
Sold 6,400 shares at $2.23 ($14k)
Fountain Nathan B, Director
No 10b5-1 planSold 11.7% of holdings ($122k position)48,150 shares leftFirst sale on recordFiling
- 8 Form 4 saleUnusualJun 17 +8 days
Sold 32,300 shares at $2.33 ($75k)
Porter Derrell, Director
No 10b5-1 planSold 47.6% of holdings ($158k position)35,500 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (43)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Porter Derrell | Director | Form 4 sale | 32,300 | $75k | 47.6% | Unusual | SEC |
| Jun 9, 2026 | Fountain Nathan B | Director | Form 4 sale | 6,400 | $14k | 11.7% | No plan | SEC |
| Mar 6, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 2,090 | $7k | 1.2% | Routine | SEC |
| Feb 27, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 9,406 | $28k | 5.1% | Routine | SEC |
| Jan 28, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 17,756 | $53k | 9.3% | Routine | SEC |
| Jan 23, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 8,934 | $17k | 4.9% | No plan | SEC |
| Jan 22, 2026 | Siemers Eric | Chief Medical Officer | Form 4 sale | 3,226 | $6k | 1.2% | No plan | SEC |
| Jan 22, 2026 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 4,160 | $8k | 1.3% | No plan | SEC |
| Jan 22, 2026 | OConnell Daniel Joseph | Chief Executive Officer | Form 4 sale | 12,035 | $22k | 1.3% | No plan | SEC |
| Jan 22, 2026 | Barton Russell | Chief Operating Officer | Form 4 sale | 2,777 | $5k | 1.3% | No plan | SEC |
| Jan 12, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 50,659 | $91k | 37.7% | Unusual | SEC |
| Jan 12, 2026 | OConnell Daniel Joseph | Chief Executive Officer | Form 4 sale | 26,472 | $47k | 4.3% | No plan | SEC |
| Jan 8, 2026 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 6,888 | $13k | 3.2% | No plan | SEC |
| Jan 8, 2026 | Barton Russell | Chief Operating Officer | Form 4 sale | 3,530 | $7k | 2.8% | No plan | SEC |
| Jan 8, 2026 | Doherty James J. | President and CDO | Form 4 sale | 8,167 | $15k | 13.1% | No plan | SEC |
| Jan 7, 2026 | Schacterle Amy | Chief Regulatory Officer | Form 4 sale | 1,097 | $2k | 12.5% | No plan | SEC |
| Jan 7, 2026 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 14,905 | $29k | 6.4% | No plan | SEC |
| Jan 7, 2026 | OConnell Daniel Joseph | Chief Executive Officer | Form 4 sale | 47,506 | $94k | 7.1% | Unusual | SEC |
| Jan 7, 2026 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 26,668 | $53k | 16.6% | No plan | SEC |
| Jan 7, 2026 | Barton Russell | Chief Operating Officer | Form 4 sale | 9,318 | $18k | 6.8% | Unusual | SEC |
| Jan 6, 2026 | Siemers Eric | Chief Medical Officer | Form 4 sale | 10,834 | $21k | 6.4% | Unusual | SEC |
| Jan 23, 2025 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 33,266 | $57k | 12.6% | Routine | SEC |
| Jan 21, 2025 | OConnell Daniel Joseph | Chief Executive Officer | Form 4 sale | 12,619 | $20k | 1.9% | Routine | SEC |
| Jan 21, 2025 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 3,418 | $5k | 2.1% | Routine | SEC |
| Jan 21, 2025 | Barton Russell | Chief Operating Officer | Form 4 sale | 2,914 | $5k | 2.1% | Routine | SEC |
| Jan 21, 2025 | Siemers Eric | Chief Medical Officer | Form 4 sale | 3,219 | $5k | 1.9% | Routine | SEC |
| Jan 3, 2025 | OConnell Daniel Joseph | Chief Executive Officer | Form 4 sale | 47,778 | $88k | 9.5% | Routine | SEC |
| Jan 3, 2025 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 11,122 | $20k | 10.2% | Routine | SEC |
| Jan 3, 2025 | Barton Russell | Chief Operating Officer | Form 4 sale | 7,636 | $14k | 7.9% | Routine | SEC |
| Jan 3, 2025 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 13,235 | $24k | 6.3% | Routine | SEC |
| Jan 3, 2025 | Siemers Eric | Chief Medical Officer | Form 4 sale | 10,859 | $20k | 9.2% | Routine | SEC |
| Jan 19, 2024 | Meisner Derek M | Officer | Form 144 notice | 8,933 | $31k | Notice | SEC | |
| Jan 19, 2024 | OConnell Daniel Joseph | Officer, Director | Form 144 notice | 15,200 | $53k | Notice | SEC | |
| Jan 19, 2024 | OConnell Daniel Joseph | President and CEO | Form 4 sale | 15,200 | $53k | 2.9% | Routine | SEC |
| Jan 19, 2024 | Meisner Derek M | Chief Legal Officer & Corp Sec | Form 4 sale | 8,933 | $31k | 7.6% | Routine | SEC |
| Jan 18, 2024 | Zuga Matt | CFO & Chief Business Officer | Form 4 sale | 4,242 | $16k | 2.0% | Routine | SEC |
| Jan 18, 2024 | Siemers Eric | Chief Medical Officer | Form 4 sale | 3,124 | $12k | 2.6% | Routine | SEC |
| Jan 18, 2024 | Barton Russell | Chief Operating Officer | Form 4 sale | 2,833 | $11k | 2.8% | Routine | SEC |
| Jan 18, 2024 | Siemers Eric | Officer | Form 144 notice | 3,124 | $12k | Notice | SEC | |
| Jan 18, 2024 | Barton Russell | Officer | Form 144 notice | 2,833 | $11k | Notice | SEC | |
| Jan 18, 2024 | Zuga Matt | Officer | Form 144 notice | 4,242 | $16k | Notice | SEC | |
| Aug 17, 2023 | Ives Jeffrey L. | Director | Form 4 sale | 41,949 | $272k | 100.0% | Routine | SEC |
| Aug 17, 2023 | Ives Jeffrey L. | Director | Form 144 notice | 41,949 | $272k | Notice | SEC |